Sculptra FDA Approval History
FDA Approved: Yes (First approved August 3, 2004)
Brand name: Sculptra
Generic name: injectable poly-L-lactic acid
Company: Sanofi-aventis U.S.
Treatment for: Facial Lipoatrophy; Facial Wrinkles
Sculptra (injectable poly-L-lactic acid) is a dermal filler indicated for the restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus. Sculptra Aesthetic is indicated for the correction of shallow to deep nasolabial fold (smile lines) contour deficiencies and other facial wrinkles in healthy patients.
Development Timeline for Sculptra
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.